Salous T, Shukla NA, Althouse SK, Perkins SM, et al. A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029. Cancer 2022 Nov 24. doi: 10.1002/cncr.34565.
PMID: 36420773